Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox |
Security Level |
 |
Mechanism |
Deferasirox: PHENobarbital may decrease the serum concentration of Deferasirox. |
Management |
Avoid combination when possible; if the combination must be used, consider an increase in initial deferasirox dose to 30 mg/kg, and monitor serum ferritin concentrations/clinical responses to guide further dosing. |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Deferasirox
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.